Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Research Into Cancer Of The Uterus Given Big Boost

Media Release
10 November 2003


Research Into Cancer Of The Uterus Given Big Boost

Research into endometrial cancer has been given extra impetus with the annoucement of a $60,000 grant for researchers at the Christchurch School of Medicine and Health Sciences, Otago University. The grant is one of six announced today by the Canterbury Medical Research Foundation, worth a total of $270,000.

Endometrial Cancer, or cancer of the lining of the uterus, is the commonest gynaecological cancer in New Zealand and most of the developed world. It’s prevalence is predicted to markedly increase in the next decade. Although most women are cured by hysterectomy, many are not. In fact death from endometrial cancer is now more common than death from cervical cancer.

“There is now a pressing need for the development of further therapeutic agents for women with this disease,” says Gynaecological Cancer Specialist, Dr Peter Sykes one of the principal investigators, along with research scientist Associate Professor John Evans.

This research will study substances which lead to the formation of blood vessels in cancer in the uterus. Tumours must have new blood vessels to develop, and researchers world wide are looking at ways of blocking this vessel growth and the supply of nutrients to cancers The School of Medicine researchers will also study the effects of female hormones and oxygen deprivation (hypoxia) on cancer tissues, which will increase understanding of the development of cancer of the uterus and provide leads to better treatment.

The research team at the School, led by Professor Evans and Dr Sykes, will collaborate with other national and international researchers exploring the growth of blood vessels (angiogenesis) which feed tumours, genetic factors and clinical management of endometrial cancer.

This project has a high priority because this cancer is common and poorly researched, and the investigation team has an approach based on a possible new strategy for treatment.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>

ALSO:

Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>

ALSO:

Results:

Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news